Open Orphan CCO Maurice Treacy discusses the early adopters of ORPH’s Genomic Health DataBANK platform on the Vox Markets Podcast November 26, 2019 – Posted in: Open Orphan (ORPH) – Tags: CCO of Open Orphan, Genomic Health Data platform, Maurice Treacy, open orphan (ORPH), orphan drug consulting services platform, Orphan drugs, Rare disease treatment, vox markets podcast
Open Orphan plc is a European-focused, rare and orphan drug consulting services platform. The Company intends to roll up a number of orphan drug services businesses. Open Orphan has two data driven digital platforms, a Genomic Health Data Platform, which is establishing a rare disease database and a Virtual Rep platform, enabling pharmaceutical companies to engage key opinion leaders and physicians. The Company is targeting rapid growth in one of the fastest growing sectors in the global pharmaceutical industry targeting under-supplied treatment for life threatening or very serious diseases and rare disorders.
(Interview starts at 10 minutes 4 seconds)